CBAN vs AROW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

CBAN

64.5
AI Score
VS
CBAN Wins

AROW

55.8
AI Score

Investment Advisor Scores

CBAN

65score
Recommendation
BUY

AROW

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBAN AROW Winner
Net Income 19.06M 24.45M AROW
ROE 4.9% 5.5% AROW
ROA 0.5% 0.5% AROW
Total Assets 3.63B 4.48B AROW
Cash 104.09M 84.24M CBAN
Debt/Equity 0.66 0.01 AROW
Free Cash Flow 61.99M 25.53M CBAN

Relative Price Performance (Last 90 Days)

CBAN 1M: -3.9% · 3M: +0.2% AROW 1M: -2.7% · 3M: -8.5%

Current Technical Phase

CBAN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.4 · Price: $20.45

AROW

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.9%) with fading momentum, RSI 47

RSI (14): 47.1 · Price: $37.79

Fundamentals Snapshot

Metric CBAN AROW
Market Cap — —
Forward P/E 8.6 8.8
Trailing P/E 12.1 11.9
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.3%
EPS 1.67 3.13
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CBAN is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.